 Livia Veress
Concepts (195)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mustard Gas | 16 | 2024 | 93 | 4.280 |
Why?
| | Chemical Warfare Agents | 15 | 2024 | 104 | 3.360 |
Why?
| | Airway Obstruction | 9 | 2024 | 162 | 2.650 |
Why?
| | Fibrin | 7 | 2024 | 91 | 1.980 |
Why?
| | Inhalation Exposure | 13 | 2018 | 115 | 1.810 |
Why?
| | Bronchitis | 4 | 2024 | 33 | 1.750 |
Why?
| | Bronchiolitis Obliterans | 3 | 2018 | 66 | 1.590 |
Why?
| | Fibrinolytic Agents | 5 | 2020 | 292 | 1.280 |
Why?
| | Respiratory Insufficiency | 5 | 2023 | 326 | 1.260 |
Why?
| | Fontan Procedure | 2 | 2021 | 191 | 1.060 |
Why?
| | Tissue Plasminogen Activator | 4 | 2020 | 244 | 0.980 |
Why?
| | Chlorine | 4 | 2024 | 64 | 0.940 |
Why?
| | Lung | 9 | 2026 | 4109 | 0.890 |
Why?
| | Pulmonary Fibrosis | 2 | 2018 | 395 | 0.830 |
Why?
| | Smoke Inhalation Injury | 1 | 2024 | 30 | 0.830 |
Why?
| | Rats, Sprague-Dawley | 18 | 2026 | 2540 | 0.780 |
Why?
| | Respiratory Mucosa | 2 | 2017 | 322 | 0.760 |
Why?
| | Epithelial Cells | 3 | 2020 | 1126 | 0.720 |
Why?
| | Cytotoxins | 1 | 2020 | 16 | 0.640 |
Why?
| | Isocyanates | 5 | 2022 | 9 | 0.630 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2021 | 157 | 0.630 |
Why?
| | Mechlorethamine | 1 | 2020 | 53 | 0.620 |
Why?
| | Rats | 17 | 2026 | 5614 | 0.600 |
Why?
| | Toxicity Tests | 2 | 2018 | 38 | 0.550 |
Why?
| | Blood Coagulation | 2 | 2018 | 268 | 0.550 |
Why?
| | Thrombolytic Therapy | 2 | 2020 | 163 | 0.540 |
Why?
| | Arterioles | 1 | 2017 | 56 | 0.520 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2020 | 557 | 0.520 |
Why?
| | Cardiac Output | 1 | 2018 | 179 | 0.520 |
Why?
| | Oxygen | 4 | 2018 | 995 | 0.480 |
Why?
| | Postoperative Care | 1 | 2018 | 288 | 0.470 |
Why?
| | Acute Lung Injury | 2 | 2016 | 303 | 0.460 |
Why?
| | Lung Diseases | 2 | 2018 | 787 | 0.420 |
Why?
| | Endothelial Cells | 1 | 2020 | 870 | 0.410 |
Why?
| | Bronchi | 3 | 2023 | 267 | 0.400 |
Why?
| | Thrombosis | 1 | 2017 | 393 | 0.400 |
Why?
| | Animals | 27 | 2026 | 38109 | 0.370 |
Why?
| | Cell Culture Techniques | 1 | 2014 | 375 | 0.340 |
Why?
| | Administration, Inhalation | 4 | 2018 | 575 | 0.330 |
Why?
| | Myocytes, Cardiac | 2 | 2015 | 556 | 0.320 |
Why?
| | Cell Proliferation | 1 | 2017 | 2499 | 0.300 |
Why?
| | Cell Differentiation | 1 | 2017 | 2050 | 0.290 |
Why?
| | Bronchoalveolar Lavage Fluid | 7 | 2018 | 636 | 0.280 |
Why?
| | Fibrinolysis | 3 | 2020 | 162 | 0.260 |
Why?
| | Respiratory Function Tests | 2 | 2018 | 547 | 0.240 |
Why?
| | Tyrosine | 2 | 2024 | 222 | 0.240 |
Why?
| | Thromboplastin | 2 | 2018 | 69 | 0.230 |
Why?
| | Postoperative Complications | 1 | 2018 | 2920 | 0.230 |
Why?
| | Male | 21 | 2026 | 72406 | 0.210 |
Why?
| | Chlorophenols | 1 | 2024 | 16 | 0.210 |
Why?
| | Lung Injury | 2 | 2017 | 237 | 0.200 |
Why?
| | Metalloporphyrins | 2 | 2016 | 66 | 0.200 |
Why?
| | Bronchoscopy | 1 | 2024 | 227 | 0.190 |
Why?
| | Disease Models, Animal | 6 | 2026 | 4569 | 0.190 |
Why?
| | Child | 5 | 2024 | 22657 | 0.190 |
Why?
| | Pesticides | 1 | 2022 | 63 | 0.180 |
Why?
| | Antioxidants | 3 | 2016 | 549 | 0.180 |
Why?
| | Gas Chromatography-Mass Spectrometry | 2 | 2018 | 131 | 0.170 |
Why?
| | Bronchopulmonary Dysplasia | 1 | 2026 | 410 | 0.170 |
Why?
| | Prenatal Exposure Delayed Effects | 2 | 2026 | 675 | 0.160 |
Why?
| | Plasminogen Activator Inhibitor 1 | 2 | 2018 | 84 | 0.160 |
Why?
| | Hemoglobins | 1 | 2022 | 384 | 0.150 |
Why?
| | Antidotes | 2 | 2024 | 145 | 0.150 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2018 | 2032 | 0.150 |
Why?
| | Hydantoins | 1 | 2018 | 7 | 0.140 |
Why?
| | Sulfur Compounds | 1 | 2018 | 8 | 0.140 |
Why?
| | Trachea | 2 | 2018 | 261 | 0.140 |
Why?
| | Oxides | 1 | 2018 | 51 | 0.140 |
Why?
| | Platelet-Derived Growth Factor | 1 | 2018 | 90 | 0.140 |
Why?
| | Humans | 14 | 2026 | 144957 | 0.140 |
Why?
| | Blood Coagulation Disorders | 1 | 2020 | 189 | 0.140 |
Why?
| | Medical History Taking | 1 | 2018 | 117 | 0.130 |
Why?
| | Receptor, Platelet-Derived Growth Factor alpha | 1 | 2018 | 54 | 0.130 |
Why?
| | Hypercapnia | 1 | 2018 | 54 | 0.130 |
Why?
| | Accidents, Occupational | 1 | 2017 | 18 | 0.130 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2018 | 178 | 0.130 |
Why?
| | Fibrin Fibrinogen Degradation Products | 1 | 2017 | 93 | 0.130 |
Why?
| | Betacoronavirus | 1 | 2020 | 286 | 0.130 |
Why?
| | Platelet Aggregation | 1 | 2017 | 105 | 0.130 |
Why?
| | Airway Remodeling | 1 | 2017 | 64 | 0.120 |
Why?
| | Physical Examination | 1 | 2018 | 240 | 0.120 |
Why?
| | Receptors, Notch | 1 | 2017 | 92 | 0.120 |
Why?
| | Computed Tomography Angiography | 1 | 2017 | 145 | 0.120 |
Why?
| | Tomography, Optical Coherence | 1 | 2018 | 271 | 0.120 |
Why?
| | Disaster Planning | 1 | 2017 | 102 | 0.120 |
Why?
| | Disasters | 1 | 2017 | 102 | 0.120 |
Why?
| | Endoscopy | 1 | 2018 | 316 | 0.110 |
Why?
| | Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2015 | 33 | 0.110 |
Why?
| | Exercise Test | 1 | 2018 | 634 | 0.110 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 384 | 0.110 |
Why?
| | Coronavirus Infections | 1 | 2020 | 378 | 0.110 |
Why?
| | Acute Disease | 1 | 2018 | 1031 | 0.110 |
Why?
| | Microdissection | 2 | 2013 | 15 | 0.110 |
Why?
| | Cell Line | 1 | 2020 | 2882 | 0.110 |
Why?
| | Imaging, Three-Dimensional | 1 | 2018 | 583 | 0.100 |
Why?
| | Pulmonary Ventilation | 1 | 2014 | 83 | 0.100 |
Why?
| | Capillary Permeability | 2 | 2014 | 134 | 0.100 |
Why?
| | Nuclear Reactors | 1 | 1993 | 2 | 0.100 |
Why?
| | Respiration | 1 | 2014 | 207 | 0.100 |
Why?
| | Electric Impedance | 1 | 2014 | 111 | 0.100 |
Why?
| | Antifibrinolytic Agents | 1 | 2014 | 62 | 0.100 |
Why?
| | Membrane Proteins | 1 | 2020 | 1167 | 0.100 |
Why?
| | Acidosis | 1 | 2014 | 105 | 0.100 |
Why?
| | Accidents | 1 | 1993 | 47 | 0.100 |
Why?
| | Immunoglobulin M | 2 | 2013 | 284 | 0.090 |
Why?
| | Drug Administration Schedule | 1 | 2014 | 783 | 0.090 |
Why?
| | Heparin | 1 | 2014 | 244 | 0.090 |
Why?
| | Environmental Exposure | 1 | 2017 | 590 | 0.090 |
Why?
| | Weight Loss | 1 | 2018 | 837 | 0.090 |
Why?
| | Lipoproteins | 1 | 2013 | 169 | 0.090 |
Why?
| | Oxidative Stress | 2 | 2016 | 1339 | 0.090 |
Why?
| | Blotting, Western | 2 | 2013 | 1187 | 0.090 |
Why?
| | Heart Diseases | 1 | 2015 | 350 | 0.090 |
Why?
| | Health Surveys | 1 | 1993 | 518 | 0.090 |
Why?
| | Time Factors | 4 | 2016 | 7183 | 0.090 |
Why?
| | Incidence | 1 | 2018 | 2883 | 0.080 |
Why?
| | Gene Expression Regulation | 1 | 2020 | 2609 | 0.080 |
Why?
| | Pneumonia | 1 | 2016 | 631 | 0.080 |
Why?
| | Algorithms | 1 | 2018 | 1839 | 0.080 |
Why?
| | Microscopy, Confocal | 1 | 2010 | 321 | 0.070 |
Why?
| | Female | 6 | 2026 | 78376 | 0.070 |
Why?
| | Limit of Detection | 2 | 2018 | 97 | 0.070 |
Why?
| | Child, Preschool | 3 | 2018 | 11799 | 0.070 |
Why?
| | Endotoxins | 1 | 2026 | 221 | 0.060 |
Why?
| | Mesna | 1 | 2024 | 16 | 0.050 |
Why?
| | Models, Animal | 2 | 2017 | 392 | 0.050 |
Why?
| | Animals, Newborn | 1 | 2026 | 902 | 0.050 |
Why?
| | Pronase | 1 | 2022 | 5 | 0.050 |
Why?
| | Sodium | 1 | 2024 | 197 | 0.050 |
Why?
| | Carbamates | 1 | 2022 | 52 | 0.050 |
Why?
| | Retrospective Studies | 2 | 2018 | 17101 | 0.050 |
Why?
| | Chromatography, Liquid | 1 | 2024 | 454 | 0.040 |
Why?
| | Blood Proteins | 1 | 2024 | 249 | 0.040 |
Why?
| | Phenols | 1 | 2022 | 114 | 0.040 |
Why?
| | Young Adult | 1 | 2018 | 14126 | 0.040 |
Why?
| | Tandem Mass Spectrometry | 1 | 2024 | 577 | 0.040 |
Why?
| | Erythrocytes | 2 | 2018 | 757 | 0.040 |
Why?
| | Reproducibility of Results | 2 | 2018 | 3415 | 0.040 |
Why?
| | Fatal Outcome | 1 | 2020 | 307 | 0.040 |
Why?
| | Biomarkers | 2 | 2022 | 4275 | 0.040 |
Why?
| | Liquid-Liquid Extraction | 1 | 2018 | 14 | 0.040 |
Why?
| | Adolescent | 1 | 2018 | 22453 | 0.030 |
Why?
| | Pregnancy | 2 | 2026 | 7191 | 0.030 |
Why?
| | Thoracic Duct | 1 | 2017 | 7 | 0.030 |
Why?
| | Chemical Terrorism | 1 | 2017 | 4 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2020 | 371 | 0.030 |
Why?
| | Mice | 1 | 2014 | 18365 | 0.030 |
Why?
| | Proteins | 2 | 2013 | 1022 | 0.030 |
Why?
| | Recovery of Function | 1 | 2020 | 710 | 0.030 |
Why?
| | Swine | 1 | 2018 | 833 | 0.030 |
Why?
| | Etiocholanolone | 1 | 2015 | 6 | 0.030 |
Why?
| | Ranolazine | 1 | 2015 | 25 | 0.030 |
Why?
| | Thiocyanates | 1 | 2015 | 28 | 0.030 |
Why?
| | Carboxypeptidase B2 | 1 | 2014 | 2 | 0.030 |
Why?
| | Embolization, Therapeutic | 1 | 2017 | 242 | 0.030 |
Why?
| | alpha-2-Antiplasmin | 1 | 2014 | 3 | 0.030 |
Why?
| | Blood-Air Barrier | 1 | 2014 | 12 | 0.030 |
Why?
| | Cardiotonic Agents | 1 | 2015 | 95 | 0.030 |
Why?
| | Mitochondria, Heart | 1 | 2015 | 102 | 0.030 |
Why?
| | Drug Administration Routes | 1 | 2014 | 44 | 0.030 |
Why?
| | Blood Coagulation Tests | 1 | 2014 | 70 | 0.030 |
Why?
| | Hungary | 1 | 1993 | 5 | 0.030 |
Why?
| | Air Pollution, Radioactive | 1 | 1993 | 3 | 0.030 |
Why?
| | Ukraine | 1 | 1993 | 35 | 0.030 |
Why?
| | Prothrombin | 1 | 2013 | 25 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2016 | 509 | 0.020 |
Why?
| | Reactive Oxygen Species | 1 | 2016 | 621 | 0.020 |
Why?
| | Indicators and Reagents | 1 | 2013 | 106 | 0.020 |
Why?
| | Calcium Signaling | 1 | 2015 | 252 | 0.020 |
Why?
| | Altitude | 1 | 2017 | 473 | 0.020 |
Why?
| | Societies, Medical | 1 | 2017 | 887 | 0.020 |
Why?
| | Adenosine Triphosphate | 1 | 2015 | 498 | 0.020 |
Why?
| | Radiation Injuries | 1 | 1993 | 151 | 0.020 |
Why?
| | Factor VII | 1 | 2011 | 25 | 0.020 |
Why?
| | Factor Xa | 1 | 2011 | 35 | 0.020 |
Why?
| | Milk Proteins | 1 | 2011 | 35 | 0.020 |
Why?
| | Cell Line, Transformed | 1 | 2011 | 140 | 0.020 |
Why?
| | Pandemics | 1 | 2020 | 1695 | 0.020 |
Why?
| | Antigens, Surface | 1 | 2011 | 157 | 0.020 |
Why?
| | Hypoxia | 1 | 2018 | 1199 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 851 | 0.020 |
Why?
| | L-Lactate Dehydrogenase | 1 | 2010 | 115 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2013 | 1371 | 0.020 |
Why?
| | Myocardium | 1 | 2015 | 939 | 0.020 |
Why?
| | Peroxidase | 1 | 2010 | 168 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2013 | 1718 | 0.020 |
Why?
| | Cytokines | 1 | 2016 | 2065 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2015 | 4155 | 0.020 |
Why?
| | Apoptosis | 1 | 2015 | 2430 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2020 | 11695 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 1993 | 6053 | 0.010 |
Why?
| | Aged | 1 | 2020 | 25947 | 0.010 |
Why?
| | United States | 1 | 2017 | 15988 | 0.010 |
Why?
| | Inflammation | 1 | 2010 | 2880 | 0.010 |
Why?
| | Middle Aged | 1 | 2020 | 35928 | 0.010 |
Why?
|
|
Veress's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|